Company / Return on Assets (ROA)
Corcept Therapeutics Incorporated Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
11.9%
FY2025
5-year range
11.9% / 22.2%
FY2021-FY2025
Trend
-29.1%
vs FY2024
Sector context
#26 of 213
Health Care
What the data says
Corcept Therapeutics Incorporated's return on assets (roa) of 11.9% is higher than 88% of companies in the Health Care sector (FY2025). Return on Assets (ROA) has declined for 4 consecutive years, from 22.2% in FY2021 to 11.9% in FY2025.
Based on SEC 10-K filings.
11.9% in FY2025 with a 5-year CAGR of -1.3%. Top quartile in the Health Care sector.
Declined from 17.1% to 11.9% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -6.3pp
- 5-Year Change
- -1.3pp
- 10-Year Change
- -
Sector benchmark
+149.3% above sector average
Key checks
Key Insights
- Corcept Therapeutics Incorporated's return on assets (roa) has declined for 4 consecutive years.
- In FY2025, return on assets (roa) decreased 29.1% year-over-year.
- Currently 36.1pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 3.44 (safe zone, above 2.9 threshold)
- Strong profit margin: 20.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 11.9% | -29.1% |
| FY2024 | 16.8% | -1.6% |
| FY2023 | 17.1% | -6.0% |
| FY2022 | 18.2% | -18.3% |
| FY2021 | 22.2% | +68.5% |
| FY2020 | 13.2% | -57.9% |
| FY2019 | 31.3% | +1100.0% |
| FY2018 | 2.6% | -95.5% |
| FY2017 | 58.6% | +228.3% |
| FY2016 | -45.6% | -269.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026